Charles River Laboratories Revenue 2010-2024 | CRL

Charles River Laboratories annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Charles River Laboratories revenue for the quarter ending December 31, 2024 was $1.003B, a 1.08% decline year-over-year.
  • Charles River Laboratories revenue for the twelve months ending December 31, 2024 was $4.050B, a 1.92% decline year-over-year.
  • Charles River Laboratories annual revenue for 2024 was $4.05B, a 1.92% decline from 2023.
  • Charles River Laboratories annual revenue for 2023 was $4.129B, a 3.86% increase from 2022.
  • Charles River Laboratories annual revenue for 2022 was $3.976B, a 12.31% increase from 2021.
Charles River Laboratories Annual Revenue
(Millions of US $)
2024 $4,050
2023 $4,129
2022 $3,976
2021 $3,540
2020 $2,924
2019 $2,621
2018 $2,266
2017 $1,858
2016 $1,681
2015 $1,363
2014 $1,298
2013 $1,166
2012 $1,130
2011 $1,143
2010 $1,133
2009 $1,172
Charles River Laboratories Quarterly Revenue
(Millions of US $)
2024-12-31 $1,003
2024-09-30 $1,010
2024-06-30 $1,026
2024-03-31 $1,012
2023-12-31 $1,013
2023-09-30 $1,027
2023-06-30 $1,060
2023-03-31 $1,029
2022-12-31 $1,100
2022-09-30 $989
2022-06-30 $973
2022-03-31 $914
2021-12-31 $905
2021-09-30 $896
2021-06-30 $915
2021-03-31 $825
2020-12-31 $791
2020-09-30 $743
2020-06-30 $683
2020-03-31 $707
2019-12-31 $691
2019-09-30 $668
2019-06-30 $658
2019-03-31 $605
2018-12-31 $602
2018-09-30 $585
2018-06-30 $585
2018-03-31 $494
2017-12-31 $478
2017-09-30 $464
2017-06-30 $469
2017-03-31 $446
2016-12-31 $467
2016-09-30 $426
2016-06-30 $434
2016-03-31 $355
2015-12-31 $354
2015-09-30 $349
2015-06-30 $340
2015-03-31 $320
2014-12-31 $330
2014-09-30 $328
2014-06-30 $341
2014-03-31 $299
2013-12-31 $289
2013-09-30 $292
2013-06-30 $293
2013-03-31 $291
2012-12-31 $280
2012-09-30 $279
2012-06-30 $285
2012-03-31 $286
2011-12-31 $291
2011-09-30 $278
2011-06-30 $288
2011-03-31 $286
2010-12-31 $282
2010-09-30 $271
2010-06-30 $289
2010-03-31 $292
2009-12-31 $264
2009-09-30 $297
2009-06-30 $308
2009-03-31 $302
Sector Industry Market Cap Revenue
Medical Medical Services $5.209B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $133.529B 24.94
Elevance Health (ELV) United States $96.108B 12.88
CVS Health (CVS) United States $84.839B 12.41
Cencora (COR) United States $55.604B 20.18
DiDi Global (DIDIY) China $20.317B 29.86
Natera (NTRA) United States $20.018B 0.00
BioMerieux (BMXMF) France $15.594B 0.00
Solventum (SOLV) United States $11.463B 10.69
ICON (ICLR) Ireland $11.251B 10.22
EUROFINS SCIENT (ERFSF) Luxembourg $11.063B 0.00
Revvity (RVTY) United States $11.032B 18.74
CochLear (CHEOY) Australia $10.876B 0.00
Avantor (AVTR) United States $10.289B 15.10
Doximity (DOCS) United States $9.934B 51.66
Viatris (VTRS) United States $9.024B 2.85
Medpace Holdings (MEDP) United States $8.956B 23.46
Sonic Healthcare (SKHHY) Australia $7.706B 0.00
HealthEquity (HQY) United States $7.311B 35.97
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Bausch + Lomb (BLCO) Canada $4.262B 19.45
Alignment Healthcare (ALHC) United States $3.499B 0.00
Sotera Health (SHC) United States $2.975B 17.18
BrightSpring Health Services (BTSG) United States $2.905B 30.18
Organon (OGN) United States $2.868B 2.92
Surgery Partners (SGRY) United States $2.708B 31.21
GeneDx Holdings (WGS) United States $2.680B 318.23
Concentras Parent (CON) United States $2.613B 13.59
Progyny (PGNY) United States $1.837B 40.45
Ardent Health Partners (ARDT) United States $1.786B 0.00
Premier (PINC) United States $1.765B 11.30
GoodRx Holdings (GDRX) United States $1.720B 37.38
Agilon Health (AGL) United States $1.649B 0.00
PACS (PACS) United States $1.411B 0.00
Teladoc Health (TDOC) United States $1.197B 0.00
Pediatrix Medical (MD) United States $1.100B 9.22
Ryman Healthcare (RYHTY) New Zealand $1.035B 0.00
CareDx (CDNA) United States $0.977B 16.62
Establishment Labs Holdings (ESTA) $0.907B 0.00
Nutex Health (NUTX) United States $0.824B 16.14
AMN Healthcare Services Inc (AMN) United States $0.706B 5.59
Embecta (EMBC) United States $0.659B 4.52
Auna S.A (AUNA) Luxembourg $0.515B 13.65
QDM (QDMI) Hong Kong, SAR China $0.496B 0.00
SBC Medicals (SBC) United States $0.417B 0.00
Sonida Senior Living (SNDA) United States $0.405B 0.00
Enhabit (EHAB) United States $0.388B 36.57
InnovAge Holding (INNV) United States $0.372B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.290B 0.00
LifeMD (LFMD) United States $0.242B 0.00
DocGo (DCGO) United States $0.216B 8.83
Performant Healthcare (PHLT) United States $0.195B 0.00
Oncology Institute (TOI) United States $0.163B 0.00
Sera Prognostics (SERA) United States $0.128B 0.00
Beauty Health (SKIN) United States $0.106B 0.00
So-Young (SY) China $0.084B 0.00
Basel Medical Group (BMGL) Singapore $0.082B 0.00
OncoCyte (OCX) United States $0.081B 0.00
Biodesix (BDSX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.053B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.018B 0.00
ModivCare (MODV) United States $0.014B 4.93
Co-Diagnostics (CODX) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
KindlyMD (KDLY) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
Aclarion (ACON) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00